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The latent reservoir for HIV is a barrier to cure, but it is unclear why HIV establishes latency given its ability to evade immune responses through evolution. Shan et al. show that latency is an unfortunate consequence of infection of CD4 + T cells within a narrow time window after activation.
SUMMARY
The latent reservoir for HIV-1 in resting memory CD4 + T cells is the major barrier to curing HIV-1 infection. Studies of HIV-1 latency have focused on regulation of viral gene expression in cells in which latent infection is established. However, it remains unclear how infection initially becomes latent. Here we described a unique set of properties of CD4 + T cells undergoing effector-to-memory transition including temporary upregulation of CCR5 expression and rapid downregulation of cellular gene transcription. These cells allowed completion of steps in the HIV-1 life cycle through integration but suppressed HIV-1 gene transcription, thus allowing the establishment of latency. CD4 + T cells in this stage were substantially more permissive for HIV-1 latent infection than other CD4 + T cells. Establishment of latent HIV-1 infection in CD4 + T could be inhibited by viral-specific CD8
INTRODUCTION
Despite extremely effective combination antiretroviral therapy (cART), HIV-1 persists in a small pool of latently infected, resting memory CD4 + T cells (Chun et al., 1995 (Chun et al., , 1997a (Chun et al., , 1997b Finzi et al., 1997; Wong et al., 1997) . Without elimination of this latent reservoir, patients cannot be cured and must receive lifelong antiretroviral treatment (Siliciano et al., 2003; Strain et al., 2003; Crooks et al., 2015) . Current approaches to purging the latent reservoir (Richman et al., 2009 ) involve pharmacologic reactivation of HIV-1 transcription by agents that reverse viral latency including protein kinase C activators (Kulkosky et al., 2001; Korin et al., 2002; Williams et al., 2004; Mehla et al., 2010; Bullen et al., 2014) , histone deacetylase inhibitors (Van Lint et al., 1996; Ylisastigui et al., 2004; Contreras et al., 2009; Archin et al., 2012; Blazkova et al., 2012; Elliott et al., 2014) , and other small compounds with unclear mechanisms (Yang et al., 2009; Xing et al., 2011) . The next step is to eliminate infected cells in which HIV-1 gene transcription has been induced by latency reversal agents (LRAs), which may require induction of viral-specific host immune responses (Shan et al., 2012) . To date, no broadly applicable strategy has been developed to effectively clear latent HIV-1 in patients. Although mechanisms for repression of HIV-1 gene expression at the transcriptional and translational levels have been well characterized, it remains unclear how HIV-1 enters a state of latency in vivo. HIV-1 genomes have been detected in several different memory cell subsets isolated from different anatomical locations in infected individuals (Chomont et al., 2009; Josefsson et al., 2013; Buzon et al., 2014 ), but the circulation and possible interconversion of these subsets makes it difficult to know how latency is initially established in vivo. Latent HIV-1 is found mainly in resting memory CD4 + T cells (Chun et al., 1997a; Pierson et al., 2000; Chomont et al., 2009) .
It is hypothesized that after infection occurs in activated CD4
+ T cells, a very small proportion of the infected cells survive viral cytopathic effects and host immune responses and revert back to a resting memory state (Chun et al., 1995) . The end result is a transcriptionally silent form of the viral genome in a long-lived memory cell. Other studies have suggested that direct infection of resting cells may result in latency (Vatakis et al., 2009; Cameron et al., 2010; Pace et al., 2012; Chavez et al., 2015) . However, resting CD4 + T cells are relatively non-permissive to productive HIV-1 infection due to blocks at the levels on entry, reverse transcription, nuclear import, and viral gene expression (Stevenson et al., 1990; Zack et al., 1990; Baldauf et al., 2012) . The entry step may be a major block for C-C chemokine receptor type 5 (CCR5)-tropic (R5) viruses due to low or absent expression of this coreceptor on most resting CD4 + T cell (Pierson et al., 2000; Dai et al., 2009) . In this study, we investigated viral entry, reverse transcription, and gene expression of R5-tropic HIV-1 in CD4 + T cells at various active or resting states. We found that activated CD4 + T cells that were transitioning to resting state in a relatively narrow time window were highly permissive for latent infection of R5-tropic HIV-1. These results may help to explain the establishment of latent infection by R5-tropic viruses in vivo.
RESULTS
Blockade of Latent Infection with CCR5-tropic HIV-1 in Activated or Resting CD4 + T Cells
The mechanisms by which latent infection is established in vivo are likely to be dependent upon the cell types that are initially infected. To better define the tropism of viruses in the latent reservoir, we performed viral outgrowth assays and analyzed the HIV-1 envelope (env) sequences of the replication-competent viruses from resting CD4 + T cells of 8 cART-treated patients. We examined a total of 28 clonal isolates of replication-competent virus from these 8 patients. Position-specific score matrix (PSSM) scores were calculated using the X4R5 matrix to predict co-receptor usage with an accuracy of 95% (Jensen et al., 2003) .
A dominant presence of replication-competent CCR5-tropic virus was found in 7 out of 8 patients. We also performed deep sequencing and quantitatively analyzed proviral env sequences from resting CD4 + T cells of an additional 11 cART-treated patients ( Figure 1B ). We found again that latent HIV-1 was predominantly CCR5-tropic (R5) (Figures 1A and 1B) . These results are consistent with previous studies using functional assays to define the tropism of latent HIV-1 (Pierson et al., 2000) . We conclude that in most patients the latent reservoir consists predominantly of R5 viruses and have thus focused our study on how latency is established by HIV-1 variants with this tropism.
To determine whether infection of activated or resting CD4 + T cells with CCR5-tropic virus can lead to HIV-1 latency, we used a previously characterized primary cell model of latency in which CD4 + T cells from healthy donors are transduced with B cell lymphoma 2 (Bcl-2), which promotes in vitro survival without altering responses to activating stimuli (Yang et al., 2009) . This model allowed us to examine events that occurred over a relatively long time scale, such as the gradual reversion of an activated CD4 + T cells to a quiescent state. Primary CD4 + T cells obtained from 12 healthy blood donors were transduced with Bcl-2 and then infected with comparable amounts of green fluorescent protein (GFP)-encoding env-reporter viruses pseudotyped with either a control C-X-C chemokine receptor type 4 (CXCR4)-tropic (X4) envelope (NL4-3) or a CCR5-tropic (R5) envelope (Yu2). Productive infection by X4 or R5 virus was observed in both activated and resting CD4 + T cells as evidenced by GFP expression 3 days after infection ( Figure 1C Figure 1D ). Figure 2C ). Altogether, these findings indicated that infection with R5 virus was unlikely to result in latency in naive, fully activated CD4 + T cells or in resting memory CD4 + T cells. For naive and activated CD4 + T cells, this was mainly due to the lack of CCR5 co-receptor expression. However, for resting memory CD4 + T cells, some of which express CCR5, this may be due to blocks at the level of reverse transcription (Korin and Zack, 1998; Baldauf et al., 2012) or integration (Bukrinsky et al., 1992) .
CCR5 Expression Is Upregulated in Effector-to-Memory Transitioning (EMT) CD4
+ T Cells, Resulting in Increased R5-tropic HIV-1 Entry Efficiency Recently activated resting memory CD4 + T cells appear to be the major cellular targets during SIV infection (Li et al., 2005) , which suggests that CD4 + T cells transitioning back to a resting state may be permissive to R5 virus infection. Although CCR5 expression was low 3 days after activation, we found that CCR5 surface expression was substantially increased 6-9 days after activation of resting CD4 + T cells. At this point, the cells were reverting back to a resting state after removal of activating stimuli. These CD4 + T cells downregulated T cell activation markers, such as CD25 and Ki67, exited the cell cycle and showed decreased size relative to fully activated cells ( Figure 3A) . We compared the phenotype of the CCR5 + and CCR5 À CD4 + T cells transitioning back to a resting state ( Figure S1 ). off HLA-DR expression, and some of them became CCR7 + .
Based on these results, we refer to both CCR5 + and CCR5 ically detects viral entry (Cavrois et al., 2002) . Our gating strategy is shown in Figure S4 . When infected with R5-tropic virus, EMT CD4 + T cells were much more permissive to viral entry than naive cells or resting memory cells ( Figure 3D ). Although a small fraction of resting memory CD4 + T cells expressed CCR5, these cells expressed significantly less surface CCR5 on a per cell basis than EMT CD4 + T cells and were correspondingly less permissive to viral entry ( Figure 3E ).
HIV-1 Gene Transcription Is Suboptimal in EMT CD4
+ T Cells
We next examined levels of HIV-1 reverse transcription and gene expression in CD4 + T cells at different activation states. As shown in Figure 2A , most CD4 + T cell populations do not express CCR5, so we delivered the HIV-1 genomes into cells by X4 virus infection to measure viral reverse transcription. By quantifying the production of late reverse transcription products (Zack et al., 1990) 24 and 72 hr after infection, we found that EMT CD4 + T cells were more permissive to HIV-1 reverse transcription than either naive or resting memory cells ( Figure 4A ). EMT CD4 + T cells were more permissive to R5-tropic virus than resting or fully activated CD4 + T cells due to higher expression of CCR5 ( Figure 4B ). However, minimal viral gene expression was observed in resting and EMT CD4 + T cells infected R5-tropic virus, while activated (day 3) cells infected with R5-tropic virus had the highest viral gene expression ( Figure 4C ). The same results were obtained when HIV-1 genomes were delivered into cells by transfection of a plasmid containing HIV-1 DNA ( Figure 4D ). Figure 5A ). Because the transcription factor NF-kB is important for initiation of HIV-1 transcription (Chan and Greene, 2012) , we specifically examined transcription of NF-kB-responsive genes, which were highly expressed in activated CD4 + T cells but were downregulated in EMT CD4 + T cells ( Figure 5A ). EMT CD4 + T cells were different from effector cells because they produced limited amount of cytokines, including INF-g and TNF-a (Figure 5B) . As NF-kB is one of the major transcription factors to regulate HIV-1 gene transcription, these data suggest that HIV-1 gene expression would be downregulated in EMT CD4 (Figure 5C ), suggesting that cellular transcription machinery turned off rather quickly after withdrawal of activating stimuli. We also observed that viral gene transcription was silenced in a small fraction of EMT CD4 + T cells (Figure 5C ). These cells showed rapid transient expression from the HIV-1 long terminal repeat (LTR) sufficient to produce detectable GFP at 24 hr after infection but had no detectable HIV-1 gag RNA. In contrast, HIV-1 transcription remained hyperactive in every single activated cell ( Figure 5C ). We believe that hypoactive HIV-1 gene transcription in EMT CD4 + T cells was likely due to a global reduction in gene transcription in cells undergoing the relaxation process, instead of specific downregulation of viral gene transcription.
HIV-1 Preferentially Establishes Latency by Infecting EMT CD4
+ T Cells To provide evidence as to whether direct infection of EMT CD4 + T cells with R5 virus could establish latency, we infected Bcl-2-transduced resting, activated, and EMT CD4 + T cells as shown in Figure S6A . Bcl-2-transduced EMT CD4 + T cells also transiently expressed high levels of surface CCR5 but became CCR5 negative when entering resting memory state ( Figure S6B ). Productive infection of these cells with X4 virus was more efficient in activated CD4 + T cells while R5 virus preferentially infected EMT CD4 + T cells ( Figure 5D ). Latent infection with R5-tropic virus was found mostly in EMT CD4 + T cells ( Figure 5E ). We also confirmed that latently infected EMT CD4 + T cells had integrated provirus rather than unintegrated HIV-1 DNA (Figure S7) . These results demonstrated that CCR5 + EMT CD4 + T cells are the primary cellular targets in which HIV-1 infection is likely to become latent. Most of the CCR5 + EMT CD4 + T cells turn off CCR5 expression as they enter quiescent memory stage. Therefore, we hypothesized that CCR5 + resting memory CD4 + T cells that maintained CCR5 expression throughout the T cell activation and/or relaxation process should be the most susceptible host cells for HIV-1 latent infection. To search for in vivo evidence, HIV-1 DNA was measured in naive, CCR5 À , and CCR5 + resting memory CD4 + T cells from cART-treated patients. As shown in Figure 6A , the frequency of HIV-1 DNA was 10-to 100-fold higher in CCR5 ( Figure 6C ), as measured by the frequency of latently infected cells in each subset and the frequency of each subset in the whole memory CD4 + T cell population. Taking the in vitro and ex vivo results together, we conclude that a fraction of activated CD4 + T cells turn on surface CCR5 expression during the relaxation stage and become permissive to latent infection of R5-tropic virus due to efficient viral entry and reverse transcription but inefficient viral transcription.
HIV-1-Specific CTLs Inhibit the Establishment of HIV-1 Latent Infection
Our results indicated that infected EMT cells transiently expressed HIV-1 proteins before shutting off viral transcription, consistent with previous reports in model systems (Pace et al., 2012; Razooky et al., 2015) . To understand whether the transient expression of viral proteins could allow cytolytic T lymphocyte (CTL) killing before latency was established, we studied CTLmediated killing of infected CD4 + T cells using a previously described primary cell system (Shan et al., 2012) . Bcl-2-transduced patient EMT CD4 + T cells were infected with R5 reporter virus and then co-cultured with pre-stimulated autologous CD8 + T cells 24 hr after infection. In our previous study, we showed that the HIV-1-infected Bcl-2-tranduced CD4 + T cells could be cleared only by pre-stimulated HIV-1-specific CTLs, but not irrelevant CTLs. In all three patients, productively infected cells (GFP + ) were gradually cleared by pre-stimulated autologous CD8 + T cells ( Figure 7A ). To investigate whether latent infection could be established under functioning CTL surveillance, frequency of latently infected cells was measured by purifying and stimulating the GFP-negative CD4 + T cell population with anti-CD3 and anti-CD28 antibodies at the end of coculture. We found that effective CTL responses significantly reduced the frequency of latent infection in all three patients tested ( Figure 7B ). These results demonstrate that functional viral-specific CTLs can rapidly kill infected CD4 + T cells before the integrated provirus becomes transcriptionally silent.
DISCUSSION
In this study, we demonstrated that in vitro, the establishment of latency occurs selectively in EMT CD4 + T cells that are transitioning back to a resting memory state. We showed here that resting or very recently activated CD4 + T cells are CCR5 À and are not permissive for infection with R5 virus. We found that a significant portion of EMT CD4 + T cells were CCR5 + . Resting memory CD4 + T cells expressing CCR5 were not as permissive as EMT CD4 + T cells to latent or productive infection likely due to inefficient reverse transcription (Korin and Zack, 1998) and integration (Bukrinsky et al., 1992) and host cell restriction factors such as SAMHD1 (Baldauf et al., 2012 ) that block various steps of the viral life cycle. After HIV-1 completes the steps in life cycle from entry to integration, the first wave of viral gene transcription is critical to the ultimate outcome of viral infection due to the viral transcriptional positive-feedback loop driven by HIV-1 Tat (Weinberger et al., 2005) . When HIV-1 initiates infection in activated CD4 + T cells, viral gene transcription is highly active and remains stably active for a significant period of time despite host cells transitioning to resting state (Razooky et al., 2015) . We found that when infection was initiated in EMT CD4 + T cells, the integrated virus produced a modest level of viral transcription that was rapidly silenced in some cells. It is likely that EMT CD4 + T cells in which latent HIV-1 infection has been established can further differentiate into effector memory, central memory, and tissue-resident memory CD4 + T cells depending on the anatomical location of infection. Our data and that of others (Puertas et al., 2016) suggests that X4-tropic virus can more efficiently establish latent infection in various subsets of CD4 + T cells including naive, activated, and memory cells ( Figures 1D, 2C , and 5E), probably due to the universal expression pattern of CXCR4 on CD4 + T cells. Therefore, the dominant presence of CCR5-tropic latent HIV-1, especially in patients who received cART during acute infection, is due not to the selective seeding of R5-tropic reservoir, but rather to a reflection of selective transmission and dominant replication of R5-tropic virus during acute and early stage of infection (Margolis and Shattock, 2006) . Given that the latent reservoir is a lifelong barrier to cure, it is important to understand its formation. In untreated patients, HIV-1 replicates continuously and avoids immune responses through rapid evolution. It has been suggested that HIV-1 latency evolved as a ''bet-hedging'' strategy to allow the virus to cross the mucosa during transmission . Given the absence of evidence for a long delay between exposure and viremia, a simple explanation supported by our data is that latency results from infection of cells in a narrow time window after activation when cells are permissive for infection but not for prolonged HIV-1 gene expression. The establishment of latent infection requires rapid downregulation of HIV-1 gene expression after initial infection to prevent viral cytopathic effects and avoid immune recognition. We demonstrated that functioning CTLs reduced the frequency of latent HIV-1 in EMT CD4 + T cells. CTLs may recognize epitopes derived from the limited amount of viral transcription that occurs in EMT CD4 + T cells and possibly also from Gag protein from the incoming virion (Sacha et al., 2007) . This may provide a mechanistic explanation of why more than 95% of the latent virus in every chronically infected patient carry escape mutations and are not recognized by the dominant CTL clones (Allen et al., 2005; Deng et al., 2015) . Studies in SIV models also indicate that pre-existing vaccine-induced T cells responses but not early cART can prevent establishment of the latent reservoir (Hansen et al., 2013) . As the major site for acute and early infection, human intestine contains large numbers of CCR5-expressing effector CD4 + T cells (Lapenta et al., 1999) , which according to our study are the primary cellular targets that support the establishment of HIV-1 latent infection. The presence of local CCR5-expressing effector CD4 + T cells may facilitate early establishment of HIV-1 latent infection which leads to persistent infection despite early cART (Whitney et al., 2014) and early emergence of HIV-1-specific CD8 + T cells (Ndhlovu et al., 2015) . Although most EMT cells turn off CCR5 expression as they return to a quiescent state, a small fraction of resting memory cells continue to express CCR5. Accordingly, we found that these cells have higher frequency of HIV-1 DNA and replicationcompetent viruses. These results are relevant to the current search for biomarkers that can identify latently infected cells (Descours et al., 2017) .
In conclusion, we have identified and characterized effectorto-memory transitioning CD4 + T cells as the major cellular target that supports the establishment of HIV-1 latent infection. We have also demonstrated how latent infection is established in these cells. Our study underscores roles of viral-specific CTLs in inhibiting the establishment of HIV-1 latent reservoir.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Robert Siliciano (rsiliciano@jhmi.edu)
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Peripheral blood for the isolation of primary CD4 + or CD8 + T cells was obtained from HIV-1-infected patients or healthy adult volunteers. Both male and female patients or volunteers were included. All patients were on cART and had maintained undetectable plasma HIV-1 RNA levels (< 50 copies per ml) for at least 6 months before blood collection. This study was approved by the Johns Hopkins Internal Review Board and the Sun Yat-sen University Internal Review Board. All human subjects were provided with written informed consent.
METHOD DETAILS
Preparation of naive, activated, EMT and resting memory CD4 + T cells
Human primary cells were cultured in RPMI1640 medium (GIBCO) containing 10% fetal bovine serum at 37 c, 5% CO 2 . Resting CD4 + T cells were isolated from healthy donors or patients with CD4 + Isolation Kit II followed by negative depletion using CD25, CD69 and HLA-DR microbeads (Miltenyi). Resting naive and memory CD4 + T cells were separated by CD45RO beads (Miltenyi). Activated CD4 + T cells were generated by co-stimulation of resting CD4 + T cells with CD3 and CD28 antibodies with the presence of IL-2 (100U/ml) for three days. To obtain EMT CD4 + T cells, activated CD4 + T cells were cultured in basal medium after removal of antibodies and cytokine. Bcl-2-transduced healthy donor or patient CD4 + T cells were generated as previously described (18). Briefly, primary CD4 + T cells were isolated from healthy donor or patients and co-stimulated with anti-CD3 and anti-CD28 antibodies for three days. Activated CD4 + T cells were then transduced with a Bcl-2-expressing lentiviral vector and cultured in basal medium without cytokines for 30 days to allow untransduced primary CD4 + T cells died off. Bcl-2-transduced cells were then used to prepare activated, EMT and resting memory CD4 + T cells in the same way as freshly isolated CD4 + T cells.
Sequencing of env sequence and prediction of co-receptor usage Patient resting memory CD4 + T cells were isolated as described above. Genomic DNA was extracted from 5 million resting CD4 + T cells from each patient using QIAamp DNAMini Kit (QIAGEN). The env gene was amplified from genomic DNA by a two round nested PCR using these primers: 5 0 outer primer (5 0 -CTGTTAAATGGCAGTCTAGC-3 0 ); 3 0 outer primer (5 0 -CACTTCTCCAATTGTCCCT CA À3 0 ); 5 0 inner primer (5 0 -ACAATGCTAAAACCATAATAGT À3 0 ); 3 0 inner primer (5 0 -CATACATTGCTTTTCCTACT À3 0 ). The PCR products were then purified, either sequenced by regular sanger sequencing or deep sequenced by Illumina Miseq platform. The deep sequencing data were collected from 11 patients, including 6 acute phase-treated (AC) and 5 chronic phase-treated (CP). For regular sequencing, the position-specific score matrix (PSSM) scores were calculated using the X4R5 matrix to predict co-receptor usage (Jensen et al., 2003) . For deep sequencing, the PSSM scores were calculated for the reads that contain the V3 loop. To remove extreme PSSM scores that are potentially resulted from sequencing error, 5% of the scores that are at the higher or the lower end of the distribution of the PSSM scores in each patient were dropped. The distribution of the remaining 95% of the PSSM scores were reported as violin plots for each patient. Note that most of the PSSM scores for sequences obtained from Patient CP35 fall outside of the confidence interval (Jensen et al., 2003) . Thus, we used the phenotypic predictor algorithm geno2pheno (http:// www.geno2pheno.org) (Beerenwinkel et al., 2003) to predict the co-receptor usage for a fraction of the reads from this patient. The false positive rate was set to 5%. The results confirm the prediction of X4 tropism viruses.
Measurement of cytokine production Naive, activated, EMT or resting memory CD4 + T cells were prepared as described above and cultured in medium for 24 hours. Culture medium was collected for the measurement of cytokine production using the Human TH1/TH2 10-Plex Tissue Culture Kit (Meso Scale Discovery, MSD).
Generation of HIV-1 reporter virus for productive and latent infection HIV-1 reporter virus NL4-3-Denv-drEGFP has a destabilized form of enhanced green fluorescent protein (Clontech) coding gene inserted into env open reading frame. To study productive and latent infection, the X4-or R5-tropic reporter virus was generated by co-transfecting 293T cells with NL4-3-Denv-drEGFP and an X4 env expression vector (pCXCR4) or R5 env expression vector (pYU2). Productive infection of freshly isolated or Bcl-2-transduced CD4 + T cells was determined by GFP expression 3 days post infection. To generate latent infection, infected cells were cultured in basal medium without supplement of antibodies or cytokine for another 15-30 days before removal of GFP-positive cells. Latent infection of Bcl-2-transduced CD4 + T cells was measured 2-3 days after reactivation of latent virus by stimulation with anti-CD3 and anti-CD28 antibodies.
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HIV-1 Entry Assay HIV-1 entry was determined by a previously described assay based on fluorescence resonance energy transfer (Cavrois et al., 2002) . Briefly, b-lactamase-Vpr virus pseudotyped with a CCR5-tropic (Yu2) envelope was used to infect primary CD4 + T cells at different activation stages. Infected cells were cultured in CCF2 loading media for 1 hour at room temperature outside of incubator. CCF2 loading media was removed afterward, and the cells were cultured in CO 2 independent media plus 10% FBS overnight at room temperature outside of incubator.
Microarray analysis
Resting, activated and EMT CD4 + T cells were generated from three healthy donors independently. Total RNA was purified using RNeasy RNA isolation kit (QIAGEN). RNA quality was assessed by Agilent 2100 bioanalyzer. cRNA were prepared according to the standard Affymetrix protocol and was hybridized to GeneChip PrimeView Human Gene Expression Array (Affymetrix, Germany).
Results are presented as means of three sets of independent donor samples.
Single cell sorting and viral RNA quantification NL4-3-Dnef-EGFP reporter virus has an enhanced green fluorescent protein coding gene inserted into nef open reading frame. Activated and EMT CD4 + T cells were generated for the infection with X4 tropic NL4-3-Dnef-EGFP. 24 hours post infection, GFP-positive cells were purified by FACS and seeded into 96 well plates at the concentration of one cell per well. Total RNA was extracted with Cells-to-cDNA IIkit (Life Technologies) followed by reverse transcription. Real-time PCR was performed using the TaqMan (Life Technologies) gene expression assay (pol2a) and the following Gag primers and probe: forward (5 0 to 3 0 ) ACATCAAGCAGCCATGCAAAT, reverse (5 0 to 3 0 ) TCTGGCCTGGTGCAATAGG, and probe (5 0 to 3 0 ) VIC-CTATCCCATTCTGCAGCTTCCTCATTGATG-TAMRA.
Measurement of HIV-1 proviral DNA and replication-competent HIV-1 in patient primary CD4 + T cells. ) were purified by FACS. Genomic DNA was collected for quantitative PCR using the same Gag primers and probe as described in viral RNA quantification. To measure frequency of latent HIV-1, CCR5
+ and CCR5 -memory CD4 + T cells (CD4RO + ) were purified by FACS and then used for limiting dilution virus outgrowth assay (Laird et al., 2016) . Briefly, CCR5
+ and CCR5 -memory CD4 + T cells were cultured with irradiated human peripheral blood mononuclear cells (PBMCs) with the presence of PHA and IL-2. PHA was removed 18 hours later. Fresh CD8 -PBMCs from healthy donors were added to the culture. Culture supernatant was collected 14 and 21 days for HIV-1 P24 ELISA.
CTL killing assay
PBMCs from HIV-1-positive patient were stimulated with a mixture of consensus B Gag peptides (800 ng/ml) (NIH AIDS Reagent Program) in the presence of IL-2 (100U/ml). CD8 + T cells were purified after six days using human CD8 microbeads (Miltenyi) before cocultured with autologous bcl-2-transduced CD4 + T cells. Bcl-2 transduction of patient CD4 + T cells were prepared as previously described (Shan et al., 2012) . Bcl-2-transduced EMT CD4 + T cells derived from patients were infected with R5-tropic reporter virus NL4-3-Denv-drEGFP. To study function of patient CTLs in prevention of latent HIV-1 infection, autologous CD8 + T cells pre-stimulated with Gag peptides mixture were added to the culture 24 hr post infection at the ratio of 1:1.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistics were performed with GraphPad Prism 6, and a P value of < 0.05 was considered significant for all comparisons. The twotailed unpaired Student's t test was used unless otherwise specified.
DATA AND SOFTWARE AVAILABILITY
The microarray data are available in the NCBI Gene Expression Omnibus (GEO: 104275). HIV env sequencing data are available in the NCBI Sequence Read Archive (SRA) (Accession number: SRP117741).
